Plastic surgeon - Dose established for acne trial
Dose established for acne trial
Photocure has finalized its first Phase II acne study. In this dose selection study, 43 patients were treated with three different doses of MAL cream and four different durations prior to light exposure.
The objective of the study was to select the best dosing regime for the Phase II confirmatory dose response study which is planned to start later this year.
The proposed acne treatment involves an application of Photocure’s patented MAL cream, followed by illumination with the company’s Aktilite lamp.
Results showed that the best dosage to reduce the number of inflammatory lesions is with lower cream concentrations and shorter light exposure sessions.
The study was conducted at two Canadian centers.
posted by Mr.Health at
11:19 AM
